These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 6056368)
1. Pharmaceutical product development from the viewpoint of the food and drug directorate. Stephenson NR Med Serv J Can; 1967 Mar; 23(3):227-32. PubMed ID: 6056368 [No Abstract] [Full Text] [Related]
2. [Standardization as a basis planning and administration in drug industry and pharmacy (II)]. Wagler M Pharm Prax; 1970; 7():151-3. PubMed ID: 5469874 [No Abstract] [Full Text] [Related]
3. [Maintaining standards of good compounding (N.B.F.)]. Castoldi B; Fumagalli A; Mazzoldi G Boll Chim Farm; 1978 Dec; 117(12):689-99. PubMed ID: 752351 [No Abstract] [Full Text] [Related]
4. [Guidelines for introducing new drugs for medical use in Poland and control of their quality]. Danysz A Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1673-4. PubMed ID: 6522321 [No Abstract] [Full Text] [Related]
5. [The EEC creates a European Medical Product Agency]. Johnson K Lakartidningen; 1993 Oct; 90(40):3395. PubMed ID: 8231477 [No Abstract] [Full Text] [Related]
6. Improving drug manufacturing with process analytical technology. Rodrigues LO; Alves TP; Cardoso JP; Menezes JC IDrugs; 2006 Jan; 9(1):44-8. PubMed ID: 16374733 [TBL] [Abstract][Full Text] [Related]
7. [Company Procter & Gamble and products of personal hygiene Always]. Misov R Akush Ginekol (Sofiia); 2004; 43 Suppl 1():3-4. PubMed ID: 15323308 [No Abstract] [Full Text] [Related]
8. A practical approach to supplier quality improvement. O'Riordan L J Parenter Sci Technol; 1991; 45(1):29-40. PubMed ID: 2007967 [TBL] [Abstract][Full Text] [Related]
9. [Responsibility for drug testing and control]. Büchi J Pharm Acta Helv; 1968 Sep; 43(9):619-27. PubMed ID: 5718866 [No Abstract] [Full Text] [Related]
10. [For the increase of qualification of engineering cadres for the chemical and pharmaceutical industry]. Blazek J Cesk Farm; 1974 Dec; 23(10):397-9. PubMed ID: 4455399 [No Abstract] [Full Text] [Related]
11. Regulatory requirements for supplemental applications: the "grey" area. Personeus GR J Parenter Sci Technol; 1989; 43(3):114-6. PubMed ID: 2732850 [No Abstract] [Full Text] [Related]
12. [International interdependence of new German pharmaceutical laws]. Hasskarl H Monogr Gesamtgeb Psychiatr Psychiatry Ser; 1978; 19():61-77. PubMed ID: 714040 [No Abstract] [Full Text] [Related]
13. The production process. Drug plant inspection by the food and drug directorate. Smyth JR Med Serv J Can; 1967 Mar; 23(3):270-6. PubMed ID: 6056372 [No Abstract] [Full Text] [Related]
14. Expectations for process validation: industry perspectives. Francis R Dev Biol (Basel); 2003; 113():9-14. PubMed ID: 14620847 [No Abstract] [Full Text] [Related]
15. Modified allergens: criteria for standardisation. Overell BG Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1988; (82):233-41. PubMed ID: 3058029 [No Abstract] [Full Text] [Related]
17. An overview of the pharmaceutical industry. Stave GM; Joines R Occup Med; 1997; 12(1):1-4. PubMed ID: 9153049 [TBL] [Abstract][Full Text] [Related]
18. The other side of process validation. Agalloco JP J Parenter Sci Technol; 1986; 40(6):251-2. PubMed ID: 3819977 [No Abstract] [Full Text] [Related]
19. Systems validation for parenteral clinical drugs--application to R&D and QC laboratories. Tetzlaff RF J Parenter Sci Technol; 1983; 37(2):45-50. PubMed ID: 6345744 [No Abstract] [Full Text] [Related]
20. Clinical trials of drugs from the viewpoint of the pharmaceutical industry. Peltier HC Clin Pharmacol Ther; 1975 Nov; 18(5 Pt 2):637-42. PubMed ID: 1102239 [No Abstract] [Full Text] [Related] [Next] [New Search]